TIDMVDN

RNS Number : 3398K

Vindon Healthcare Plc

29 July 2013

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

   1.         KEY INFORMATION 
 
 (a) Identity of the party to the offer making the disclosure:                                 Vindon Healthcare Plc 
--------------------------------------------------------------------------------------------  ------------------------ 
 (b) Owner or controller of interests and short positions disclosed, if different from 1(a):   n/a 
  The naming of nominee or vehicle companies is insufficient 
--------------------------------------------------------------------------------------------  ------------------------ 
 (c) Name of offeror/offeree in relation to whose relevant securities this form relates:       Vindon Healthcare Plc 
  Use a separate form for each party to the offer 
--------------------------------------------------------------------------------------------  ------------------------ 
 (d) Is the party to the offer making the disclosure the offeror or the offeree?               OFFEREE 
--------------------------------------------------------------------------------------------  ------------------------ 
 (e) Date position held:                                                                       26 July 2013 
--------------------------------------------------------------------------------------------  ------------------------ 
 (f) Has the party previously disclosed, or is it today disclosing, under the Code in          NO 
 respect                                                                                        If YES, specify which: 
 of any other party to this offer? 
--------------------------------------------------------------------------------------------  ------------------------ 
 
   2.         POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 
 Class of relevant security: 
-------------------------------------------------  -------------------------------- 
                                                     Interests     Short positions 
-------------------------------------------------  ------------  ------------------ 
                                                    Number    %      Number      % 
-------------------------------------------------  --------      -------------  --- 
 (1) Relevant securities owned and/or controlled: 
-------------------------------------------------  --------      -------------  --- 
 (2) Derivatives (other than options): 
-------------------------------------------------  --------      -------------  --- 
 (3) Options and agreements to purchase/sell: 
-------------------------------------------------  --------      -------------  --- 
 
   TOTAL: 
-------------------------------------------------  --------      -------------  ---

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

   (b)        Rights to subscribe for new securities 
 
 Class of relevant security in relation to which subscription right exists: 
---------------------------------------------------------------------------- 
 Details, including nature of the rights concerned and relevant percentages: 
----------------------------------------------------------------------------

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

   (c)        Irrevocable commitments and letters of intent 
 
 Details of any irrevocable commitments or letters of intent procured by the party to the offer 
  making the disclosure or any person acting in concert with it (see Note 3 on Rule 2.11 of 
  the Code): 
----------------------------------------------------------------------------------------------- 
 
 
   3.         POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE 
 
 Details of any interests, short positions and rights to subscribe of any person acting in 
  concert with the party to the offer making the disclosure: 
--------------------------------------------------------------------------------------------------- 
 
   Martin Liam Ferguson (Chairman) 
   4,150,000 ordinary shares of 1p each, representing 4.67% of the issued share capital of Vindon 
   Healthcare Plc. 
 
   Thomas Patrick Jackson (Business Development Director) 
   3,000,000 ordinary shares of 1p each, representing 3.38% of the issued share capital of Vindon 
   Healthcare Plc. 
 
   Ian Gordon (Technical Director) 
   Options over 2,000,000 ordinary shares of 1p each. The exercise price of each option is 0.05p 
   and the exercise period is from 9 December 2008 to 8 December 2015. These options are over 
   issued shares that are held by Vindon Healthcare Plc's employee benefit trust, Vindon Healthcare 
   EBT Trustees Limited. 
 
   Richard Ian Hughes (Non Executive Director) 
   15,200,349 ordinary shares of 1p each, representing 17.11% of the issued share capital of 
   Vindon Healthcare Plc. 
 
   Martin Henry Burrill (Non Executive Director) 
   300,000 ordinary shares of 1p each, representing 0.34% of the issued share capital of Vindon 
   Healthcare Plc. 
---------------------------------------------------------------------------------------------------

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3 for each additional class of relevant security.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

   4.         OTHER INFORMATION 
   (a)        Indemnity and other dealing arrangements 
 
 Details of any indemnity or option arrangement, or any agreement or understanding, formal 
  or informal, relating to relevant securities which may be an inducement to deal or refrain 
  from dealing entered into by the party to the offer making the disclosure or any person acting 
  in concert with it: 
  If there are no such agreements, arrangements or understandings, state "none" 
------------------------------------------------------------------------------------------------ 
 None 
------------------------------------------------------------------------------------------------ 
 
   (b)        Agreements, arrangements or understandings relating to options or derivatives 
 
 Details of any agreement, arrangement or understanding, formal or informal, between the party 
  to the offer making the disclosure, or any person acting in concert with it, and any other 
  person relating to: 
  (i) the voting rights of any relevant securities under any option; or 
  (ii) the voting rights or future acquisition or disposal of any relevant securities to which 
  any derivative is referenced: 
  If there are no such agreements, arrangements or understandings, state "none" 
---------------------------------------------------------------------------------------------- 
 
   None 
---------------------------------------------------------------------------------------------- 
 
   (c)        Attachments

Are any Supplemental Forms attached?

 
 Supplemental Form 8 (Open Positions)   NO 
-------------------------------------  --- 
 Supplemental Form 8 (SBL)              NO 
-------------------------------------  --- 
 
 
 Date of disclosure:    29 July 2013 
---------------------  -------------- 
 Contact name:          Jon Scopes 
---------------------  -------------- 
 Telephone number:      01706 716 710 
---------------------  --------------

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS

The company news service from the London Stock Exchange

END

FEELIFFDDSIAFIV

Vindon Healthcare (LSE:VDN)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Vindon Healthcare Charts.
Vindon Healthcare (LSE:VDN)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Vindon Healthcare Charts.